Indiana officials accuse Zionsville medical-device maker of violating securities law
The Secretary of State’s Securities Division announced the action Tuesday against VoCare Inc. and three of its officers.
The Secretary of State’s Securities Division announced the action Tuesday against VoCare Inc. and three of its officers.
In his ruling, the judge emphasized that each side agreed about the need for more research on the long-term effects of gender-transition procedures.
In an hourlong conference call with analysts on Monday, CEO Jeff Simmons said the word “blockbuster” at least six times as he talked about the Greenfield-based company’s pipeline products that could launch this year.
The probe involves U.S. attorneys in various parts of the country who are investigating organ procurement organizations in at least five states.
While inpatient medical and surgical volumes across the system did not return to pre-pandemic levels, IU Health reported strong outpatient growth in 2023.
The Indianapolis-based medical school ranked 29th in the country for landing funding from the National Institutes of Health.
About 37 million American have diabetes, which requires close monitoring of blood sugar levels. A doctor said using the unapproved devices could result in inaccurate blood sugar measurements, with potentially devastating consequences.
Alan Sword, who sold Medicare Advantage plans on behalf of Anthem, was suspended in an emergency order issued Jan. 30 by Amy Beard, commissioner of the Indiana Department of Insurance.
Shares in the Indianapolis-based drugmaker are setting new records almost every day, due to investor excitement over the company’s new drugs for obesity and diabetes, two health conditions that plague America.
EMS providers say insurance stinginess is complicating their financial stability and forcing them to hand big bills to unwitting Hoosiers.
A major Louisiana health insurer’s plan to reorganize and sell itself to Indianapolis-based insurance giant Elevance Health was shelved after critics of the sale voiced various concerns over the proposal.
The U.S. Food and Drug Administration designated psilocybin as a “breakthrough therapy” for treatment-resistant depression in 2018 and for major depressive disorder in 2019.
An Israeli company has firmed up plans for a new isotope manufacturing plant in Westfield in what is becoming a scramble in a red-hot local market for nuclear-medicine facilities.
Estimates predict that Indiana would need an additional 5,000 nurses by 2031, equal to graduating an additional 1,300 nurses each year until that time, according to the Indiana Hospital Association.
As Novo and Lilly fight to dominate the market in weight-loss drugs, gaining an edge in manufacturing power is emerging as a new front. Both drugmakers are racing to secure the highly specialized plants that can churn out enough of their top-selling drugs to keep up with demand.
Indianapolis-based Marathon said the merger will extend services to 2.5 million eligible patients and more than 630 U.S. employer and union-sponsored clients.
At 6-foot-11, former Indiana Pacers center Scot Pollard’s size helped him play more than a decade in the NBA, earning him a championship ring with the 2008 Boston Celtics. Now, it might be killing him.
Several Indiana employers, universities and health care organizations have launched the Indiana Business Health Collaborative, a new partnership that wants to improve Indiana’s health profile through private-sector solutions.
A state legislative committee held a nearly eight-hour meeting to consider the proposed sale of Blue Cross and Blue Shield of Louisiana to Indianapolis-based Elevance.
Indianapolis-based Eli Lilly and Co. and Switzerland-based Novartis were the most active acquirers in the past 12 months, with seven and six deals respectively, according to data compiled by Bloomberg.